Patent Assignment
Reel/Frame 074407/0426
Assignment of Assignor's Interest
Recorded: 2026-02-05
Pages: 24
Assignor
NUTCRACKER THERAPEUTICS, INC.
Executed: 2026-02-05
Assignee
MEDICI THERAPEUTICS, INC.
240 LONGWOOD AVENUE, SUITE 125, BOSTON, MASSACHUSETTS, 02115
Covered Properties
(46)
Apparatus with Dynamic Light Scattering Assembly
Application:
17/964,185 →
Publication:
US 2023/0035784
Therapeutic Composition Comprising an Isolated Messenger Ribonucleic Acid (Mrna) Polynucleotide
Application:
63/416,241 →
Mrna Treatment Nanoparticles
Modified 5' Utr
Application:
18/713,508 →
Publication:
US 2025/0019710
Apparatus and Method to Screen Reagents for in Vitro Transcription
Application:
63/430,139 →
Mrna Therapeutic Compositions
Application:
63/434,219 →
Mrna Therapies Including Sirp-Alpha
Application:
63/480,596 →
Mrna Therapeutic Compositions
Application:
63/442,566 →
Mrna Therapies Including Sirp-Alpha
Application:
63/483,881 →
Mrna Therapeutic Compositions
Application:
63/444,195 →
Microfluidic Apparatus with Elastic Layers and Contoured Surface
Application:
63/453,206 →
Analytical Method for Characterization of Rna in Lipid Nanoparticles
Application:
63/468,623 →
Mrna Therapeutic Compositions
Application:
63/495,412 →
5'-C Alkyl Substituted Rna Caps and Methods of Use
Application:
63/497,620 →
Mixing and Microfluidic Apparatuses Related Thereto
Rna Cap Analogs and Methods of Use
Application:
18/867,199 →
Publication:
US 2025/0215043
Customized Codon Sequences
Application:
63/472,647 →
Comparative Assessment of Nanoparticle Delivery Vehicles
Application:
63/521,480 →
Microfluidic Apparatus and Methods of Use Thereof
Ethyl Modified Rna Caps and Methods of Use
Application:
63/524,050 →
Mrna Therapies Including Sirp-Alpha
Application:
18/995,050 →
Publication:
US 2026/0103501
2-Aminopropane-1,3-Diol-Capped Cationic Peptoids for Nucleic Acid Delivery
Application:
19/108,894 →
Publication:
US 2026/0083769
Mrna Therapeutic Compositions
Microfluidic Chip Assembly with Metal Undercarriage
Application:
63/548,286 →
Mrna Treatment Nanoparticles
Multivalent Antibody Constructs for Targeting Prostrate Cancer Cells
Application:
63/607,994 →
Degradable Peptoids
Application:
63/612,009 →
Method for Isolating and Characterizing Proteins
Application:
63/621,829 →
Apparatus and Method for Treating Rna with Beads
Application:
63/551,768 →
Rna Purification Methods
Application:
63/563,990 →
Mrna Therapeutic Compositions
Mrna Treatment Nanoparticles
Patent:
12,121,577 →
Application:
18/606,473 →
Multivalent Antibody Constructs for Targeting Prostate Cancer Cells
Application:
63/631,088 →
5’-C Alkyl Substituted Rna Caps and Methods of Use
Application:
19/167,922 →
Microfluidic Apparatus and Methods of Use Thereof
Application:
18/649,451 →
Publication:
US 2024/0287497
Mrna Therapeutic in a Lipid Delivery with Multiple Targeting Against CD19, CD20, and/or CD47
Application:
63/649,868 →
Customized Codon Sequences
Application:
63/656,247 →
Ethyl Modified Rna Caps and Methods of Use
Application:
18/759,011 →
Publication:
US 2025/0026779
State Machine Based Script Applications and Systems
Application:
18/793,178 →
Publication:
US 2024/0394071
Microfluidic Apparatus with Asymmetrical Chambers
Application:
63/681,918 →
Polynucleotide Manufacturing Unit with Automatic Lift
Application:
63/686,288 →
Mixing and Microfluidic Apparatuses Related Thereto
Application:
18/816,662 →
Publication:
US 2024/0416342
Mrna Therapeutic Compositions
Application:
18/901,083 →
Publication:
US 2025/0082742
Mrna Therapeutic in a Lipid Delivery with Multiple Targeting Against CD19, CD20, and/or CD47
Application:
63/614,412 →
Apparatuses and Methods for Measuring Dna/Rna Production in Biochips
Apparatus with Dynamic Light Scattering Assembly
Application:
19/177,288 →
Publication:
US 2025/0258081
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 9, 2023
From: ELDRIDGE, BENJAMIN; WEN, XIMIAO; CHU, ERIC; CZIMMERMAN, TAMAS
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 062637/0351 →
Assignment of Assignor's Interest
Jun 8, 2023
From: HAABETH, OLE; KANNAN, GUNA
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 063896/0934 →
Assignment of Assignor's Interest
Jul 20, 2023
From: CHU, ERIC; CZIMMERMAN, TAMAS; ELDRIDGE, BENJAMIN; JORDAN, KENNETH
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 064328/0299 →
Assignment of Assignor's Interest
Sep 22, 2023
From: MCKINLAY, COLIN JAMES; WOO-DERLETH, WAN LU
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 064993/0038 →
Assignment of Assignor's Interest
Nov 17, 2023
From: MCCARTNEY-MELSTAD, EVAN MERLE; DEUTSCH, SAMUEL
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 065603/0287 →
Assignment of Assignor's Interest
Nov 27, 2023
From: DEUTSCH, SAMUEL; FAY, NICOLE; FRIMANNSSON, DANIEL; HAABETH, OLE
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 065668/0955 →
Assignment of Assignor's Interest
Dec 7, 2023
From: EBRIGHT, SOPHIA; WEN, XIMIAO; SANII, BABAK
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 065805/0223 →
Assignment of Assignor's Interest
Dec 19, 2023
From: BANDI, SRINIVASA; RAE, CHRIS; KANNAN, GUNA
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 065906/0313 →
Assignment of Assignor's Interest
Jan 2, 2024
From: HAABETH, OLE; KANNAN, GUNA
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 065993/0791 →
Assignment of Assignor's Interest
Jan 10, 2024
From: MCKINLAY, COLIN JAMES; HABIBIAN, MARYAM
To: NUTCRACKER THERAPEUTICS, INC
Reel/Frame 066083/0786 →
Assignment of Assignor's Interest
Feb 19, 2024
From: AKOPIAN, DAVID; HERNANDEZ, ARMONDO; CHOU, CHIH-LING
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 066488/0149 →
Assignment of Assignor's Interest
Mar 13, 2024
From: MCKINLAY, COLIN JAMES; GHOLIZADEH, SHIMA
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 066754/0742 →
Assignment of Assignor's Interest
Mar 22, 2024
From: PHILPOT, ROSALIE; CHEN, PING WEI; WEN, XIMIAO
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 066864/0209 →
Assignment of Assignor's Interest
Apr 3, 2024
From: KANNAN, GUNASEKARAN; LEONG, MEREDITH; DEUTSCH, SAMUEL; HAABETH, OLE
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 066991/0669 →
Assignment of Assignor's Interest
May 2, 2024
From: COSMAN, JASON
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 067296/0605 →
Assignment of Assignor's Interest
May 20, 2024
From: JOHNSON, JAMES; FUOCO, CASEY; CHEN, PING-WEI; SANII, BABAK
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 067468/0001 →
Assignment of Assignor's Interest
Jun 3, 2024
From: COSMAN, JASON
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 067600/0669 →
Assignment of Assignor's Interest
Jun 3, 2024
From: SANII, BABAK; JOHNSON, JAMES; WEN, XIMIAO; CHEN, PING-WEI
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 067600/0664 →
Assignment of Assignor's Interest
Jun 12, 2024
From: HSU, PEI-KEN; NATH, SANGEETA
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 067700/0398 →
Assignment of Assignor's Interest
Jun 25, 2024
From: YU, NING; CAI, WEI; FUOCO, CASEY; ELDRIDGE, BENJAMIN
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 067832/0726 →
Assignment of Assignor's Interest
Jul 25, 2024
From: LOW, RAY; ADUSUMILLI, GOWRISUDHA; KANNAN, GUNASEKARAN
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 068087/0801 →
Assignment of Assignor's Interest
Aug 13, 2024
From: HAABETH, OLE; KANNAN, GUNASEKARAN
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 068261/0588 →
Assignment of Assignor's Interest
Aug 16, 2024
From: HAABETH, OLE; KANNAN, GUNASEKARAN 1
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 068307/0129 →
Corrective Assignment to Correct the Name of Inventor Kannan by Removing the "1" Between His Given and Surnames Previously Recorded on Reel 68307 Frame 129. Assignor(S) Hereby Confirms the Original Assignment.
Aug 23, 2024
From: HAABETH, OLE; KANNAN, GUNASEKARAN
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 068958/0667 →
Assignment of Assignor's Interest
Sep 7, 2024
From: DEUTSCH, SAMUEL; FAY, NICOLE; FRIMANNSSON, DANIEL; HAABETH, OLE
To: NUTCRACKER THERAPEUTICS, INC.
Reel/Frame 068519/0889 →